EICVX | RMEBX | EICVX / RMEBX | |
Total Expense Ratio | 1.21 | 1.07 | 113% |
Annual Report Gross Expense Ratio | 1.25 | 1.07 | 117% |
Fund Existence | 14 years | 11 years | - |
Gain YTD | 10.761 | 9.733 | 111% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 250 | 1,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 341M | 109B | 0% |
Annual Yield % from dividends | 1.84 | 1.12 | 164% |
Returns for 1 year | 11.05 | 10.33 | 107% |
Returns for 3 years | 27.38 | 29.87 | 92% |
Returns for 5 years | 68.85 | 60.87 | 113% |
Returns for 10 years | 56.70 | 75.73 | 75% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GSLIX | 16.70 | N/A | N/A |
Goldman Sachs Large Cap Value Instl | |||
PMFMX | 23.11 | N/A | N/A |
Principal MidCap S&P 400 Index R3 | |||
VTSNX | 148.36 | N/A | N/A |
Vanguard Total Intl Stock Index I | |||
JFNCX | 54.93 | N/A | N/A |
Janus Henderson Global Life Sciences C | |||
CBGAX | 14.28 | N/A | N/A |
ClearBridge Global Infrastructure Inc C |